ATE243521T1 - Verwendung von biopolymeren zur behandlung der muskeln - Google Patents

Verwendung von biopolymeren zur behandlung der muskeln

Info

Publication number
ATE243521T1
ATE243521T1 AT95915222T AT95915222T ATE243521T1 AT E243521 T1 ATE243521 T1 AT E243521T1 AT 95915222 T AT95915222 T AT 95915222T AT 95915222 T AT95915222 T AT 95915222T AT E243521 T1 ATE243521 T1 AT E243521T1
Authority
AT
Austria
Prior art keywords
pct
biopolymers
sec
date
pub
Prior art date
Application number
AT95915222T
Other languages
English (en)
Inventor
Denis Barritault
Jean-Pierre Caruelle
Pascal Desgranges
Jean Gautron
Anne Meddahi
Original Assignee
Valbiofrance
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valbiofrance filed Critical Valbiofrance
Application granted granted Critical
Publication of ATE243521T1 publication Critical patent/ATE243521T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95915222T 1994-03-30 1995-03-29 Verwendung von biopolymeren zur behandlung der muskeln ATE243521T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403803A FR2718026B1 (fr) 1994-03-30 1994-03-30 Médicament et composition pharmaceutique pour le traitement des muscles.
PCT/FR1995/000398 WO1995026736A1 (fr) 1994-03-30 1995-03-29 Utilisation de biopolymeres pour le traitement des muscles

Publications (1)

Publication Number Publication Date
ATE243521T1 true ATE243521T1 (de) 2003-07-15

Family

ID=9461614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95915222T ATE243521T1 (de) 1994-03-30 1995-03-29 Verwendung von biopolymeren zur behandlung der muskeln

Country Status (9)

Country Link
US (1) US5852003A (de)
EP (1) EP0752862B1 (de)
JP (1) JPH10503472A (de)
AT (1) ATE243521T1 (de)
CA (1) CA2186760C (de)
DE (1) DE69531150T2 (de)
ES (1) ES2202358T3 (de)
FR (1) FR2718026B1 (de)
WO (1) WO1995026736A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781485B1 (fr) 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
FR2781375A1 (fr) * 1998-07-21 2000-01-28 Denis Barritault Composition anti-fibrotique contenant des polymeres ou biopolymeres et leurs utilisations
FR2781374B1 (fr) * 1998-07-21 2001-06-29 Denis Barritault Composition antioxydante comprenant au moins un polymere ou biopolymere seul ou associe a la sod
FR2794976B1 (fr) * 1999-06-16 2004-05-07 Solutions Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
US7538097B2 (en) * 2000-09-26 2009-05-26 Halozyme, Inc. Inhibition of antigen presentation with poorly catabolized polymers
FR2861308A1 (fr) 2003-10-28 2005-04-29 Organes Tissus Regeneration Re Utilisation de polymeres biocompatibles pour la preparation d'une composition pharmaceutique, dermatologique ou cosmetique destinee a la prevention, au soulagement ou au traitement des genes, desagrements et douleurs
JP5026791B2 (ja) 2003-10-28 2012-09-19 オルガンズ ティシューズ リジェネレーション リパレーション レムプレースメント − オーティーアール３ 医療用化合物あるいは医療用製品を作成するための生体適合性ポリマーの使用方法
FR2907014B1 (fr) * 2006-10-17 2009-05-15 Engelhard Lyon Sa Utilisation d'actifs cosmetiques pour proteger le fibroblaste growth factor-beta ou fgf-2 de la matrice extracellulaire dans le but de restructurer cette matrice
FR2914191A1 (fr) * 2007-03-29 2008-10-03 Proteins & Peptides Man Composition angiogenique.
US8193220B1 (en) * 2009-08-20 2012-06-05 Alan Brown Scott Method of changing muscle lengths with anesthetic drugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461724A1 (fr) * 1979-07-20 1981-02-06 Christine Fougnot Polymeres substitues par des groupes leur conferant des proprietes anti-coagulantes et leur procede de preparation, objets constitues par et/ou comprenant lesdits polymeres et leurs procedes de fabrication, application desdits objets en chirurgie et en medecine, et compositions pharmaceutiques contenant lesdits polymeres substitues
FR2555589B1 (fr) * 1983-11-30 1986-05-16 Choay Sa Nouveaux derives du dextrane a activites anticoagulante en anti-inflammatoire, leur procede de preparation et utilisation de ces derives en tant qu'anticoagulants et en tant que substituts du plasma sanguin
FR2644066B1 (fr) * 1989-03-09 1994-05-13 Therapeutiques Substitutives Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques

Also Published As

Publication number Publication date
CA2186760A1 (fr) 1995-10-12
FR2718026B1 (fr) 1997-01-17
DE69531150T2 (de) 2004-04-29
EP0752862B1 (de) 2003-06-25
ES2202358T3 (es) 2004-04-01
US5852003A (en) 1998-12-22
CA2186760C (fr) 2007-10-30
JPH10503472A (ja) 1998-03-31
DE69531150D1 (de) 2003-07-31
EP0752862A1 (de) 1997-01-15
FR2718026A1 (fr) 1995-10-06
WO1995026736A1 (fr) 1995-10-12

Similar Documents

Publication Publication Date Title
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE202785T1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
ATE256475T1 (de) Verwendung von follistatin zur herstellung eines arzneimittels zur behandlung von muskuläre krankheiten
DE69523745D1 (de) Gel zur behandlung von hauterkrankungen und zur desinfizierung von haut
ATE316786T1 (de) Behandlung von mukositis
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE59410052D1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
ATE228846T1 (de) Verwendung von biopolymeren zur behandlung von verletzungen des verdauungstraktes
ATE217197T1 (de) Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa
ATE243521T1 (de) Verwendung von biopolymeren zur behandlung der muskeln
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE320263T1 (de) Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie
DE69124382D1 (de) Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände
DE69421705T2 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
ATE200865T1 (de) Verwendung von phosphorderivaten von alkaloiden zur behandlung von endokrinopathien
DE69832796D1 (de) Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen
UA36490A (uk) Спосіб лікування гнійно-септичних захворювань м'яких тканин

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0752862

Country of ref document: EP

REN Ceased due to non-payment of the annual fee